Approval · Notice of Compliance 30608 · 2023
ZORYVE: Notice of Compliance 30608
Issued April 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30608
- Date
- April 28, 2023
- Company
- Arcutis Biotherapeutics, Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZORYVE | 02537532 | Marketed |
Medicinal ingredients
- ROFLUMILAST 0.3 PER